 But the progress in gene therapy is promising for the future of treating primary immunodeficiencies.A survey of 10,000 American households revealed that the prevalence of diagnosed primary immunodeficiency approaches 1 in 1200.This figure does not take into account people with mild immune system defects who have not received a formal diagnosis.